Novel Peptides Targeting Metabolic Disease

AmideBio is leveraging its in-silico design and proprietary peptide synthesis capabilities to develop a pipeline of unique peptide drug candidates targeting some of the biggest therapeutic challenges for metabolic disease. In addition, we  provide custom synthesis services and a portfolio of peptides to customers seeking high purity, low cost solutions.